Literature DB >> 29448312

Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.

Gilton M Fonseca1, Evandro S de Mello2, Sheila F Faraj2, Jaime A P Kruger1, Fabricio F Coelho1, Vagner B Jeismann1, Renato M Lupinacci3, Ivan Cecconello1, Venancio A F Alves2, Timothy M Pawlik4, Paulo Herman1.   

Abstract

BACKGROUND: Histomorphological features have been described as prognostic factors after resection of colorectal liver metastases (CLM). The objectives of this study were to assess the prognostic significance of tumor budding (TB) and poorly differentiated clusters (PDC) among CLM, and their association with other prognostic factors.
METHODS: We evaluated 229 patients who underwent a first resection of CLM. Slides stained by HE were assessed for TB, PDC, tumor border pattern, peritumoral pseudocapsule, peritumoral, and intratumoral inflammatory infiltrate. Lymphatic and portal invasion were evaluated through D2-40 and CD34 antibody.
RESULTS: Factors independently associated with poor overall survival were nodules>4 (P = 0.002), presence of PDC G3 (P = 0.007), portal invasion (P = 0.005), and absence of tumor pseudocapsule (P = 0.006). Factors independently associated with disease-free survival included number of nodules>4 (P < 0.001), presence of PDC G3 (P = 0.005), infiltrative border (P = 0.031), portal invasion (P = 0.006), and absent/mild peritumoral inflammatory infiltrate (P = 0.002). PDC and TB were also associated with histological factors, as portal invasion (TB), peritumoral inflammatory infiltration (PDC), infiltrative border, and absence of tumor pseudocapsule (TB and PDC).
CONCLUSIONS: This is the first study demonstrating PDC as a prognostic factor in CLM. TB was also a prognostic factor, but it was not an independent predictor of survival.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal liver metastases; liver resection; poorly differentiated cluster; prognosis; tumor budding

Mesh:

Year:  2018        PMID: 29448312     DOI: 10.1002/jso.25017

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size?

Authors:  Vitoria Ramos Jayme; Gilton Marques Fonseca; Isaac Massaud Amim Amaral; Fabricio Ferreira Coelho; Jaime Arthur Pirola Kruger; Vagner Birk Jeismann; Rafael Soares Nunes Pinheiro; Evandro Sobroza de Mello; Paulo Herman
Journal:  Ann Surg Oncol       Date:  2021-04-08       Impact factor: 5.344

Review 2.  Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Authors:  Emily Latacz; Diederik Höppener; Ali Bohlok; Vincent Donckier; Peter M Siegel; Raymond Barnhill; Marco Gerling; Cornelis Verhoef; Peter B Vermeulen; Sophia Leduc; Sébastien Tabariès; Carlos Fernández Moro; Claire Lugassy; Hanna Nyström; Béla Bozóky; Giuseppe Floris; Natalie Geyer; Pnina Brodt; Laura Llado; Laura Van Mileghem; Maxim De Schepper; Ali W Majeed; Anthoula Lazaris; Piet Dirix; Qianni Zhang; Stéphanie K Petrillo; Sophie Vankerckhove; Ines Joye; Yannick Meyer; Alexander Gregorieff; Nuria Ruiz Roig; Fernando Vidal-Vanaclocha; Larsimont Denis; Rui Caetano Oliveira; Peter Metrakos; Dirk J Grünhagen; Iris D Nagtegaal; David G Mollevi; William R Jarnagin; Michael I D'Angelica; Andrew R Reynolds; Michail Doukas; Christine Desmedt; Luc Dirix
Journal:  Br J Cancer       Date:  2022-06-01       Impact factor: 9.075

3.  Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.

Authors:  Cássio Virgílio Cavalcante de Oliveira; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Evandro Sobroza de Mello; Fabricio Ferreira Coelho; Paulo Herman
Journal:  Histol Histopathol       Date:  2020-11-09       Impact factor: 2.303

Review 4.  Tumour budding and its clinical implications in gastrointestinal cancers.

Authors:  Inti Zlobec; Martin D Berger; Alessandro Lugli
Journal:  Br J Cancer       Date:  2020-06-30       Impact factor: 7.640

5.  Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis.

Authors:  Mi Jian; Wenju Chang; Li Ren; Tianyu Liu; Yijiao Chen; Ye Wei; Qi Lin; Jianmin Xu; Xinyu Qin
Journal:  Cancer Manag Res       Date:  2019-09-11       Impact factor: 3.989

6.  Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.

Authors:  Annika Blank; Carla Schenker; Heather Dawson; Guido Beldi; Inti Zlobec; Alessandro Lugli
Journal:  Front Med (Lausanne)       Date:  2019-10-31

7.  Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.

Authors:  Yingcheng Zhang; You Liu; Xiaomei Qiu; Bing Yan
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

8.  Survival outcomes in unresectable metastatic rectal cancer patients after both primary site resection and chemoradiotherapy: a SEER-based observational study.

Authors:  Jianan Chen; Haipeng Chen; Fuqiang Zhao; Zheng Wang; Qian Liu
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.